Related Experiment Video
Updated: Aug 5, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
The Myeloma Risk Variant of TNFRSF13B Shows Reduced NF-κB Signalling Activity in HEK293 Cells
Richard Muyan Chen1, Jackie L Ludgate1, Robert J Weeks1
1Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.
Abstract:
A single nucleotide variant rs34562254 in TNFRSF13B, which encodes TACI (transmembrane activator and CAML interactor), is associated with an increased risk of myeloma and MGUS. This variant encodes a proline to leucine substitution at residue 251 in the long isoform (P251L) and residue 205 in the short isoform (P205L) of TACI. Using HEK293 cells, NF-κB signalling of the variant and wild type forms of TACI was measured by using an NF-κB-luciferase reporter assay and by quantifying NF-κB p65 subcellular localisation. The TACI P205L variant showed substantially reduced NF-κB activity compared to the wild type version of the short isoform. This result suggests an indirect effect of TACI P205L on the increased risk of myeloma.
Insights
A genetic variant in TNFRSF13B, encoding TACI (transmembrane activator and CAML interactor), is linked to myeloma risk. The TACI P205L variant shows reduced NF-κB activity, suggesting an indirect role in disease development.
Area of Science:
- Immunology
- Genetics
Background:
- A single nucleotide variant (rs34562254) in TNFRSF13B, encoding TACI, is associated with increased risk of myeloma and MGUS.
- This variant results in a proline to leucine substitution at residue 251 (long isoform) or 205 (short isoform) of TACI.
Purpose of the Study:
- To investigate the functional impact of the TACI P205L variant on NF-κB signaling.
- To explore the potential indirect mechanism linking TACI P205L to myeloma risk.
Main Methods:
- Utilized HEK293 cells for experiments.
- Assessed NF-κB signaling using an NF-κB-luciferase reporter assay.
- Quantified NF-κB p65 subcellular localization.
Main Results:
- The TACI P205L variant exhibited significantly reduced NF-κB activity compared to the wild-type short isoform.
- NF-κB p65 subcellular localization patterns may differ between variant and wild-type TACI.
Conclusions:
- The reduced NF-κB activity associated with the TACI P205L variant suggests an indirect contribution to the increased risk of myeloma.
- Further research is warranted to fully elucidate the role of TACI signaling in myeloma pathogenesis.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Abnormal Proliferation

